Navigation Links
Video: New FDA-Approved Sun Protectant Saves Skin All Year Round

L'Oreal Paris Revitalift UV with Mexoryl(TM) SX

NEW YORK, Oct. 15 /PRNewswire/ -- L'Oreal Paris, the worldwide leader in anti-aging skincare, introduces Revitalift UV Daily Moisturizing Cream with Mexoryl SX (ecamsule), a new daily moisturizer with advanced UV protection that protects against both short and long UVA rays -- the number one cause of skin aging. After years of research and testing, the revolutionary Mexoryl SX technology, exclusive to L'Oreal, has been approved in a formula by the FDA and is finally available to American consumers.

To view the Multimedia News Release, go to:

But sun protection is not just a summer issue. Studies from the American Academy of Dermatology reveal that even as weather cools, the sun's powerful rays pose a strong threat, contributing to skin cancers and premature aging of the skin. "What most people don't realize is that UVA rays are present year round, even on the cloudiest days, and they are able to penetrate glass," says Dr. Lydia Evans, a New York-based dermatologist.

However, not all UV protection is created equal. Mexoryl SX (ecamsule) is the latest FDA-approved sun filter to give advanced protection against UVA rays. Used in Europe and throughout the world for over 13 years, it is now widely available in the United States at drugstores and mass market retailers nationwide in the form of L'Oreal Paris Revitalift UV Daily Moisturizing Cream with Mexoryl SX. Mexoryl SX offers protection from both short and long UVA rays, along with broad spectrum UVB SPF15 coverage.

Now that skin can be protected from short UVA rays, a critical gap in the UV spectrum has been filled. "UVA rays penetrate the epidermis, reaching the dermis to negatively impact cell metabolism and the DNA of healthy cells," says Dr. Evans. "The result of this, in the worst cases, is skin cancer, but it is also the primary cause of skin aging -- loss of firmness, premature wrinkles and discoloration."

Dermatologists acknowledge that advanced UVA protection is the smartest thing you can do to fight the signs of skin aging. Mexoryl SX is now recommended by 25,000 dermatologists worldwide.

For more information on L'Oreal Paris Revitalift UV Daily Moisturizing Cream with Mexoryl SX, visit

SOURCE L'Oreal Paris
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Drug saves heroin addicts
2. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
3. B Vitamin Supplementatoin Saves Money and Lives
4. Senior drug card saves little
5. Dead Palestinian Boy Saves Lives Of Six Others
6. Expert Patient Program saves Hospital fund
7. Berlin Heart Saves The Life Of An Eighteen Month Old Child
8. Interim OPD saves the day for patients
9. Aspirin Saves Life Even in Cancer Patients
10. Mammography Saves Life-Beware Women Over 40
11. British Doctor of Indian Origin Saves Bihar Womans Life
Post Your Comments:
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary ... Periwinkle Pioneers, nominated by the public, will receive special recognition throughout 2016 as ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 --> ... devices was valued at $11,171.1 million in 2014, and ... 5.7% during 2015 - 2022. The global market is ... of diabetes. In addition, the increase in obese population ... to the growth of the market. Furthermore, technological advancements ...
Breaking Medicine Technology: